Arkolith/Insider Trading/VRDN/Form 4

Katz Barrett

Chief Medical OfficerViridian Therapeutics, Inc.\DE (VRDN) · full profile →Form 4 · filed Jan 11, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.1M
Net Open-Market Flow
-$2.1M
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 10, 2023Option exercise(M)47K$23.03$1.1M47K
Jan 10, 2023Sell(S)47K$35.30$1.7M0
Jan 9, 2023Option exercise(M)13K$23.03$291K13K
Jan 9, 2023Sell(S)13K$33.04$417K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 10, 2023Option exercise(M)47K—$0296K
Jan 9, 2023Option exercise(M)13K—$0343K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-001626) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML